Peachy brings in Stride Consumer Partners to scale its specialized aesthetics studio model
Peachy has secured a minority investment from Stride Consumer Partners. Read how the deal could reshape branded aesthetics growth in 2026.
Tracsis (LSE: TRCS) acquires Vesputi GmbH to plant its digital ticketing flag in Germany
Tracsis (TRCS) acquires German digital ticketing firm Vesputi for €5.8m, targeting Germany's Mobilitybox platform and public transport market. Read full analysis.
Is Everus Construction Group building a stronger pharma and industrial moat through the SE&M acquisition?
Everus Construction Group is buying SE&M for $158 million to expand in the Southeast. Read what the deal means for growth, margins, and investor sentiment.
Why Sweden’s $180m BAE Systems order could matter far beyond one air-defence contract
BAE Systems plc wins a $180 million Sweden contract for Tridon Mk2. Read what the deal signals for European air defence, backlog strength, and investors.
Can Off The Hook YS Inc. turn Bellhart Marine into a margin engine for boat resale growth?
Off The Hook YS is buying Bellhart Marine to deepen marine service capacity and margin control. Read what the deal could mean for OTH next.
Why Bed Bath & Beyond (NYSE: BBBY) sees The Container Store deal as more than a retail acquisition
Bed Bath & Beyond is buying The Container Store to expand home services, stores, and margins. Read what the $150 million deal could change next.
LandBridge (NYSE: LB) and PowerBridge seal 2 GW data center campus deal in West Texas as AI-driven land monetisation accelerates
LandBridge and PowerBridge target a 2 GW data center campus in West Texas. Here is what the Alpha Digital Campus deal means for investors and the AI infrastructure race. Read more.
Why Context Therapeutics (NASDAQ: CNTX) jumped on CTIM-76 fast track status and what comes next
Context Therapeutics stock rose after CTIM-76 won FDA fast track status. Read what it means for CNTX, ovarian cancer strategy, and the June 2026 data catalyst.
Can Plug Power finally turn project wins into proof of scale with this 275 MW Canada deal?
Plug Power won a 275 MW electrolyzer role in Canada’s Courant project. Read why the deal matters for PLUG, green hydrogen scale, and mining demand.
Why Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) just strengthened the Eylea HD case against Roche’s Vabysmo
Regeneron won FDA approval for every-20-week Eylea HD dosing in wet AMD and DME. Read what it means for Regeneron, rivals, and retinal drug markets.